Assessing Efficacy of Alternate-Day Buprenorphine Dosing
Data Collection
Narcotic-Related Disorders+2
+ Mental Disorders
+ Opioid-Related Disorders
Treatment Study
Summary
Study start date: November 1, 1994
Actual date on which the first participant was enrolled.This study focuses on individuals who are on a daily maintenance dose of a medication called buprenorphine. The main goal is to find out if taking four times the usual daily dose can last for 96 hours without any changes in its effects. This is important because it could potentially simplify treatment plans for those who require this medication, making it more convenient and manageable. The study is in its second phase, which means it's still in the early stages of testing this new approach.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 21 to 48 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Please contact site for information.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location